ARTG Entry
RELISTOR
ARTG entry for RELISTOR (methylnaltrexone bromide), ARTG 144062 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Link Pharmaceuticals
- Active ingredient: methylnaltrexone bromide
- Therapeutic area: Gastroenterology
What it is
Relistor is a methylnaltrexone bromide 12 mg/0.6 mL solution for injection.
Regulatory history
Relistor was first listed on the ARTG on 17 November 2008.